Making great products even greater

Canada’s leader in Graphene production and application solutions

Making great products even greater​

Canada’s leader in Graphene production and application solutions

GLCM Biosensor Test & Platform

Our Response to COVID-19

GLC Medical (GLCM) Inc. has completed the validation of the SARS-CoV-2 vertical on the GLCM Biosensor Platform. Validation work was completed at the University of Alberta, Li Ka Shing Institute of Virology and University of Sherbrooke. The GLCM Biosensor Test Platform produces results in under one-minute and can be tailored to detect multiple pathogens. This diagnostic device represents a global breakthrough in medical diagnostics by providing real-time virus detection that is unmatched in terms of sensitivity, simplicity, and reproducibility by utilizing electrochemical impedance spectroscopy (EIS).         

GLCM - Company Video

Play Video

What We Do

We produce disruptive graphene-enhanced technology solutions for an evolving world market

Play Video

Our Graphene

Our graphene materials serve as a platform technology to add value across numerous applications. GLC is specifically focused on the environment and coatings markets.


GLC’s production of bulk nanomaterials include Graphene Oxide (GO), Reduced Graphene Oxide (rGO) and Pristine Graphene (pG) and serve as a platform of products available in customizable solvents and in flake form.


GLC is focused on working with industries to develop solutions by integrating graphene to develop new innovative and first-to-market products and solutions.

In The News

Check out our latest news posting and publications.

Looking for more?

We are expanding the global economy. Our technology is available to license and will have a monumental impact for future generations.
GLC is currently seeking strategic partners and welcomes all inquiries and discussions.
For more information, please email us at